EUVIMEDEUVIMED entdecken
Crossref

Preclinical toxicological assessment of amido-bridged nucleic acid-modified antisense oligonucleotides targeting synaptotagmin XIII for intra-abdominal treatment of peritoneal metastasis of gastric cancer

Mitsuro Kanda iD, Nao Takano, Hiroshi Miyauchi, Kohei Ueda, Masaaki Mizuno, Yuuya Kasahara, Yasuhiro Kodera, Satoshi Obika

Gastric Cancer · 2024

DOI: 10.1007/s10120-024-01548-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gastric Cancer, 2024. Verfasst von Mitsuro Kanda und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan. m-kanda…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Peritoneal Neoplasms, Macaca fascicularis, Synaptotagmins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsPeritoneal NeoplasmsMacaca fascicularisSynaptotagminsOligonucleotides, AntisenseAnimalsMiceRatsMaleFemaleHumansRats, Sprague-Dawley

Stichwörter der Autor:innen

Antisense oligonucleotideGastric cancerIntra-abdominal treatmentPeritoneal metastasisSynaptotagmin XIII

Substanzen

SynaptotagminsOligonucleotides, Antisense

Autor:innen und Institutionen

  • Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan. m-kanda@med.nagoya-u.ac.jp.
  • Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.
  • Center for Advanced Medicine and Clinical Research, Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan.
  • National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka, Japan.
  • Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.

ORCID-Profile: Mitsuro Kanda

Zitieren

APA

Kanda, M., Takano, N., Miyauchi, H., Ueda, K., Mizuno, M., Kasahara, Y., Kodera, Y., & Obika, S. (2024). Preclinical toxicological assessment of amido-bridged nucleic acid-modified antisense oligonucleotides targeting synaptotagmin XIII for intra-abdominal treatment of peritoneal metastasis of gastric cancer. Gastric Cancer. https://doi.org/10.1007/s10120-024-01548-9

Vancouver

Kanda M, Takano N, Miyauchi H, Ueda K, Mizuno M, Kasahara Y, et al. Preclinical toxicological assessment of amido-bridged nucleic acid-modified antisense oligonucleotides targeting synaptotagmin XIII for intra-abdominal treatment of peritoneal metastasis of gastric cancer. Gastric Cancer. 2024. doi:10.1007/s10120-024-01548-9

BibTeX
@article{Kanda2024,
  author = {Kanda, Mitsuro and Takano, Nao and Miyauchi, Hiroshi and Ueda, Kohei and Mizuno, Masaaki and Kasahara, Yuuya and Kodera, Yasuhiro and Obika, Satoshi},
  title = {Preclinical toxicological assessment of amido-bridged nucleic acid-modified antisense oligonucleotides targeting synaptotagmin XIII for intra-abdominal treatment of peritoneal metastasis of gastric cancer},
  journal = {Gastric Cancer},
  year = {2024},
  doi = {10.1007/s10120-024-01548-9}
}
Kostenlos starten →